Scholars@Duke publication: ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET)

ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET)

Publication , Journal Article

Gururangan, S; Grant, GA; Driscoll, T; Archer, G; Sayour, EJ; Herndon, JE; Friedman, HS; Kurtzberg, J; Bigner, DD; Sampson, JH; Mitchell, DA

Published in: PEDIATRIC BLOOD & CANCER

September 1, 2013

Link to item

Duke Scholars

Author James Emmett Herndon II Biostatistics & Bioinformatics, Division of Biostatistics

Author Henry Seth Friedman Neurosurgery, Neuro-Oncology

Author Joanne Kurtzberg Pediatrics, Transplant and Cellular Therapy

Author Darell Doty Bigner Neurosurgery

Author John Howard Sampson Neurosurgery

Published In

PEDIATRIC BLOOD & CANCER

EISSN

1545-5017

ISSN

1545-5009

Publication Date

September 1, 2013

Volume

Start / End Page

13 / 13

Publisher

WILEY-BLACKWELL

Related Subject Headings

Oncology & Carcinogenesis
3213 Paediatrics
3211 Oncology and carcinogenesis
1114 Paediatrics and Reproductive Medicine
1112 Oncology and Carcinogenesis
1103 Clinical Sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Gururangan, S., Grant, G. A., Driscoll, T., Archer, G., Sayour, E. J., Herndon, J. E., … Mitchell, D. A. (2013). ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER, 60, 13–13.

Gururangan, S., G. A. Grant, T. Driscoll, G. Archer, E. J. Sayour, J. E. Herndon, H. S. Friedman, et al. “ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET).” PEDIATRIC BLOOD & CANCER 60 (September 1, 2013): 13–13.

Gururangan S, Grant GA, Driscoll T, Archer G, Sayour EJ, Herndon JE, et al. ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER. 2013 Sep 1;60:13–13.

Gururangan, S., et al. “ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET).” PEDIATRIC BLOOD & CANCER, vol. 60, WILEY-BLACKWELL, Sept. 2013, pp. 13–13.

Gururangan S, Grant GA, Driscoll T, Archer G, Sayour EJ, Herndon JE, Friedman HS, Kurtzberg J, Bigner DD, Sampson JH, Mitchell DA. ADOPTIVE LYMPHOCYTE THERAPY (ALT) PLUS DENDRITIC CELL VACCINATION (DCV) AFTER MYELOABLATIVE (MA) OR NON-MYELOABLATIVE (NMA) CONDITIONING IN PATIENTS WITH RECURRENT CENTRAL PNET (C-PNET). PEDIATRIC BLOOD & CANCER. WILEY-BLACKWELL; 2013 Sep 1;60:13–13.

Published In

PEDIATRIC BLOOD & CANCER

EISSN

1545-5017

ISSN

1545-5009

Publication Date

September 1, 2013

Volume

Start / End Page

13 / 13

Publisher

WILEY-BLACKWELL

Related Subject Headings

Oncology & Carcinogenesis
3213 Paediatrics
3211 Oncology and carcinogenesis
1114 Paediatrics and Reproductive Medicine
1112 Oncology and Carcinogenesis
1103 Clinical Sciences